JP2023145686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023145686A5 JP2023145686A5 JP2023126654A JP2023126654A JP2023145686A5 JP 2023145686 A5 JP2023145686 A5 JP 2023145686A5 JP 2023126654 A JP2023126654 A JP 2023126654A JP 2023126654 A JP2023126654 A JP 2023126654A JP 2023145686 A5 JP2023145686 A5 JP 2023145686A5
- Authority
- JP
- Japan
- Prior art keywords
- exo
- isx
- cpcs
- cpc
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/881,693 US20180273906A1 (en) | 2014-04-17 | 2018-01-26 | Microvesicle and stem cell compositions for therapeutic applications |
| US15/881,693 | 2018-01-26 | ||
| JP2019011767A JP2019201631A (ja) | 2018-01-26 | 2019-01-28 | 治療用微小胞と幹細胞の合成 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019011767A Division JP2019201631A (ja) | 2018-01-26 | 2019-01-28 | 治療用微小胞と幹細胞の合成 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023145686A JP2023145686A (ja) | 2023-10-11 |
| JP2023145686A5 true JP2023145686A5 (https=) | 2025-02-04 |
| JP7837302B2 JP7837302B2 (ja) | 2026-03-30 |
Family
ID=68725220
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019011767A Pending JP2019201631A (ja) | 2018-01-26 | 2019-01-28 | 治療用微小胞と幹細胞の合成 |
| JP2023126654A Active JP7837302B2 (ja) | 2018-01-26 | 2023-08-03 | 治療用途のための微小胞および幹細胞組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019011767A Pending JP2019201631A (ja) | 2018-01-26 | 2019-01-28 | 治療用微小胞と幹細胞の合成 |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US20180273906A1 (https=) |
| JP (2) | JP2019201631A (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3888640B1 (en) | 2013-06-05 | 2025-09-17 | Reverse Bioengineering, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
| US20180273906A1 (en) * | 2014-04-17 | 2018-09-27 | Muhammad Ashraf | Microvesicle and stem cell compositions for therapeutic applications |
| CN108779435B (zh) | 2015-12-07 | 2022-05-03 | 再生疗法有限公司 | 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法 |
| KR20180057546A (ko) * | 2016-11-21 | 2018-05-30 | 성균관대학교산학협력단 | 지방줄기세포유래 엑소좀을 유효성분으로 포함하는 간 섬유증 예방 또는 치료용 조성물 |
| JP7538044B2 (ja) * | 2018-04-30 | 2024-08-21 | ザ チルドレンズ メディカル センター コーポレーション | 間葉系間質細胞エキソソームおよびそれらの使用 |
| CN109266603A (zh) * | 2018-08-29 | 2019-01-25 | 浙江大学 | 一种提高心梗疗效的外泌体及应用 |
| US12508325B2 (en) | 2018-12-20 | 2025-12-30 | Ohio State Innovation Foundation | Compositions and methods for reprogramming diseased musculoskeletal cells |
| WO2020132161A1 (en) * | 2018-12-21 | 2020-06-25 | The Regents Of The University Of California | Compositions and methods for treating hearing loss |
| CA3135200A1 (en) * | 2019-03-28 | 2020-10-01 | Agex Therapeutics, Inc. | Induced tissue regeneration using extracellular vesicles |
| WO2020206272A2 (en) * | 2019-04-03 | 2020-10-08 | The Johns Hopkins University | Methods, compositions, and kits for producing skeletal muscle stem cells and treating disorders |
| US20220233604A1 (en) * | 2019-05-15 | 2022-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating cardiomyocytes |
| CN110257333A (zh) * | 2019-05-27 | 2019-09-20 | 江苏大学 | 一种神经干细胞微囊泡及其应用 |
| CN110724665A (zh) * | 2019-11-21 | 2020-01-24 | 西安外事学院 | 一种iPS细胞培养上清液及其制备方法和应用 |
| WO2021114164A1 (zh) * | 2019-12-12 | 2021-06-17 | 中国科学院深圳先进技术研究院 | 一种外泌体及其制备方法及应用 |
| CN115175986B (zh) | 2020-02-10 | 2024-11-08 | 公立大学法人名古屋市立大学 | 用于诱导多能干细胞向脑毛细血管内皮样细胞分化的涂布剂及其利用 |
| CN111961645A (zh) * | 2020-09-01 | 2020-11-20 | 杭州优渡生物科技有限公司 | 一种高效扩增人表皮成纤维细胞的培养基 |
| TW202227615A (zh) * | 2020-10-14 | 2022-07-16 | 日商達芬奇環球股份有限公司 | 心肌幹/前驅細胞之製作方法及心肌纖維化抑制方法 |
| JP2023550453A (ja) * | 2020-11-18 | 2023-12-01 | 富士フイルム株式会社 | セクレトーム含有組成物の生成、並びにその使用及び分析方法 |
| CN114645021A (zh) * | 2020-12-21 | 2022-06-21 | 未来智人再生医学研究院(广州)有限公司 | 一种表达靶向cd47抑制因子的多能干细胞及其衍生物与应用 |
| CN112608972B (zh) * | 2020-12-21 | 2021-09-10 | 广东源心再生医学有限公司 | Myog基因作为靶点在制备治疗心肌细胞凋亡相关的心血管疾病的药物中的应用 |
| CN114657130A (zh) * | 2020-12-22 | 2022-06-24 | 未来智人再生医学研究院(广州)有限公司 | 一种表达vegf-a靶向抑制因子的多能干细胞及其衍生物与应用 |
| CN113209135B (zh) * | 2021-04-23 | 2023-06-13 | 奥启(深圳)生物科技有限公司 | 一种用于延缓皮肤衰老的间充质干细胞外泌体制剂 |
| CN113322226A (zh) * | 2021-06-28 | 2021-08-31 | 华南理工大学 | 三维培养胚胎干细胞来源的外泌体及在制备治疗肝纤维化药物的应用 |
| JPWO2023079655A1 (https=) * | 2021-11-04 | 2023-05-11 | ||
| WO2023136313A1 (ja) * | 2022-01-14 | 2023-07-20 | 国立大学法人大阪大学 | 肝機能障害を処置するための組成物 |
| US20250154115A1 (en) * | 2022-02-11 | 2025-05-15 | The University Of North Carolina At Chapel Hill | Arylbenzoisoxazole compounds as ip6k and ipmk inhibitors and methods of use thereof |
| KR102816689B1 (ko) * | 2022-03-29 | 2025-06-02 | 박동선 | Tsg101 단백질을 암호화하는 폴리뉴클레오티드가 도입된 줄기세포 및 이의 용도 |
| PL443827A1 (pl) * | 2023-02-18 | 2024-08-19 | Uniwersytet Jagielloński | Sposób otrzymywania pęcherzyków zewnątrzkomórkowych (EVs) pochodzących z indukowanych pluripotencjalnych komórek macierzystych (iPSC) oraz ich zastosowanie |
| WO2025117472A1 (en) * | 2023-11-30 | 2025-06-05 | Immorta Bio, Inc. | Treatment of heart failure using pluripotent stem cell derived cardiomyocytes and derivatives thereof |
| WO2025160404A1 (en) * | 2024-01-26 | 2025-07-31 | FUJIFILM Cellular Dynamics, Inc. | Generation of secretome-containing compositions, and methods of using and analyzing the same |
| WO2025247999A1 (en) * | 2024-05-30 | 2025-12-04 | Conveyxo | Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles |
| EP4656187A1 (en) * | 2024-05-30 | 2025-12-03 | ConvEyXo | Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles |
| CN120131648B (zh) * | 2025-03-06 | 2025-11-25 | 上海市重大传染病和生物安全研究院 | 一种hiv-1潜伏感染激活剂、药物及用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150297638A1 (en) * | 2014-04-17 | 2015-10-22 | Muhammad Ashraf | Chemically induced pluripotent stem cells for safe therapeutic applications |
| US20180273906A1 (en) | 2014-04-17 | 2018-09-27 | Muhammad Ashraf | Microvesicle and stem cell compositions for therapeutic applications |
| US10443044B2 (en) | 2014-04-17 | 2019-10-15 | Ips Heart | Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds |
| JP6845500B2 (ja) | 2014-12-29 | 2021-03-17 | 国立大学法人京都大学 | 骨格筋前駆細胞の製造方法 |
| EP3455346A1 (en) | 2016-05-12 | 2019-03-20 | Erasmus University Medical Center Rotterdam | A method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium |
-
2018
- 2018-01-26 US US15/881,693 patent/US20180273906A1/en active Pending
-
2019
- 2019-01-28 JP JP2019011767A patent/JP2019201631A/ja active Pending
-
2020
- 2020-02-19 US US16/795,217 patent/US20210054344A1/en not_active Abandoned
-
2023
- 2023-08-03 JP JP2023126654A patent/JP7837302B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023145686A5 (https=) | ||
| Goradel et al. | Stem cell therapy: a new therapeutic option for cardiovascular diseases | |
| Bollini et al. | Resident cardiac progenitor cells: at the heart of regeneration | |
| Burdon et al. | Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential | |
| Hida et al. | Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells | |
| Moon et al. | The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction | |
| CN103340902B (zh) | 含有心源性因子的组合物和相关方法、细胞，以及所述组合物、方法和细胞的应用 | |
| de Macedo Braga et al. | In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction | |
| US8771677B2 (en) | Colony-forming unit cell of human chorion and method to obtain and use thereof | |
| US20220387518A1 (en) | Immortalized cardiac stem cells for cardiac repair | |
| JP2009531021A (ja) | 骨格筋周囲血管芽細胞および心筋中胚葉性血管芽細胞、それらの単離および使用方法 | |
| US20130330825A1 (en) | Attachment substrates for directed differentiation of human embryonic stem cells in culture | |
| CN106163572A (zh) | 用于诱导体细胞直接转分化为血管祖细胞的组合物及其用途 | |
| WO2022135279A1 (zh) | Myog基因作为靶点在制备治疗心肌细胞凋亡相关的心血管疾病的药物中的应用 | |
| Devarajan et al. | Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype | |
| Pagano et al. | Normal versus pathological cardiac fibroblast‐derived extracellular matrix differentially modulates cardiosphere‐derived cell paracrine properties and commitment | |
| Sharma et al. | Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome | |
| Morrissette-McAlmon et al. | Adipocyte-mediated electrophysiological remodeling of human stem cell-derived cardiomyocytes | |
| US9969978B2 (en) | Method for producing cardiomyocytes from human or mouse embryonic stem cells in a medium consisting of a serum-free medium and N2 supplement | |
| CN115369077B (zh) | Meflc细胞株及其构建方法和应用 | |
| US8513011B2 (en) | Methods and compositions for culturing cardiomyocyte-like cells | |
| CN102888401A (zh) | 一种诱导多功能干细胞的抑制剂、其诱导方法和用途 | |
| Lou | Tissue Engineered Cardiac Muscle Patches with Human Pluripotent Stem Cells Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model | |
| Lou | Human Pluripotent Stem Cells and Patches Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model | |
| Poudel et al. | Increased cardiogenesis in P19-GFP teratocarcinoma cells expressing the propeptide IGF-1Ea |